Gene · 6240
Papers3,003
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,003
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. | Elife | 2026 | 41498402 | PubTator, text mining | PubMed |
| Structural investigation of human U6 snRNA recognition by spliceosomal recycling factor SART3 RNA recognition motifs. | FEBS J | 2026 | 41046346 | PubTator, text mining | PubMed |
| Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia. | ASPET Discov | 2025 | 42422326 | PubTator, text mining | PubMed |
| Ubiquitin signatures on aggregating proteins in neurodegeneration. | Essays Biochem | 2025 | 41837791 | PubTator, text mining | PubMed |
| Clinical application and drug resistance mechanism of gemcitabine. | Front Cell Dev Biol | 2025 | 41293424 | PubTator, text mining | PubMed |
| Self-assembled phenylboronic acid nanomedicine targets sialic acid to synergistically activate ferroptosis via RRM1 suppression and GPX4 Inhibition for precision colon cancer therapy. | J Nanobiotechnology | 2025 | 41291810 | PubTator, text mining | PubMed |
| Bavachalcone targets transferrin receptor and sensitizes gemcitabine to affect bladder cancer progression. | Imeta | 2025 | 41112054 | PubTator, text mining | PubMed |
| In Silico Structural Modeling of the HuR-mRNA Complex: Insights into Structural and Functional Regulation. | J Chem Inf Model | 2025 | 41032726 | PubTator, text mining | PubMed |
| EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers. | Nat Commun | 2025 | 41006228 | PubTator, text mining | PubMed |
| Decoding the functional roles of circular RNAs linked to NF-κB pathway in carcinogenesis. | Discov Oncol | 2025 | 40996665 | PubTator, text mining | PubMed |
| The MLLT3 YEATS domain is a dual reader of histone marks (H3K9/18/27ac/cr) and ncRNA (7SK), linking epigenetic and RNA signaling to regulate hematopoiesis. | bioRxiv | 2025 | 40950097 | PubTator, text mining | PubMed |
| Structural insights into IMP2 dimerization and RNA binding. | J Struct Biol | 2025 | 40946981 | PubTator, text mining | PubMed |
| 1H, 13C and 15N backbone resonance assignment of the RNA binding motif 39 (RBM39) tandem RNA recognition motifs (RRM1-2). | Biomol NMR Assign | 2025 | 40944856 | PubTator, text mining | PubMed |
| Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cells. | Biochem Pharmacol | 2025 | 40925467 | PubTator, text mining | PubMed |
| Role of CPEBs in Learning and Memory. | J Neurochem | 2025 | 40916649 | PubTator, text mining | PubMed |
| Selective targeting of TBXT with DARPins identifies regulatory networks and therapeutic vulnerabilities in chordoma. | Sci Adv | 2025 | 40901948 | PubTator, text mining | PubMed |
| CUB domain-containing protein 1 signaling dysregulates gemcitabine metabolism contributing to therapeutic resistance in T24 cells. | PLoS One | 2025 | 40892739 | PubTator, text mining | PubMed |
| SLFN11, far from being limited to responding to cancer DNA damage. | Clin Exp Med | 2025 | 40856812 | PubTator, text mining | PubMed |
| Landscape analysis of m5C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinoma. | Clin Epigenetics | 2025 | 40847321 | PubTator, text mining | PubMed |
| Identification of biomarkers and potential therapeutic targets of breast cancer using bioinformatics analysis. | Medicine (Baltimore) | 2025 | 40826700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6240/papers?page=3